Michael Liebowitz, MD: The Mental Health Impact of COVID-19

September 28, 2020
Kenny Walter

Kenny Walter is an editor with HCPLive. Prior to joining MJH Life Sciences in 2019, he worked as a digital reporter covering nanotechnology, life sciences, material science and more with R&D Magazine. He graduated with a degree in journalism from Temple University in 2008 and began his career as a local reporter for a chain of weekly newspapers based on the Jersey shore. When not working, he enjoys going to the beach and enjoying the shore in the summer and watching North Carolina Tar Heel basketball in the winter.

For many patients suffering from depression or anxiety, the added stress of the pandemic has led to a medication change.

The ongoing coronavirus disease 2019 (COVID-19) pandemic might be having a tremendous mental health impact across the country.

Between lockdowns and social distancing measures, the everyday life for nearly everyone in the US has been upended with no restart date in sight.

For some, this upheaval in routine is having a profound and lasting impact on their collective mental health.

Michael R Liebowitz, MD, a professor of clinical psychiatry at Columbia University, explained in an interview with HCPLive® just how damaging the pandemic has been for both patients suffering from psychiatric disorders like anxiety and for other individuals who did not previously have a psychiatric diagnosis.

While the pandemic is having obvious health and financial impacts on many throughout the world, Liebowitz explained how the significant change in daily routine, coupled with the inability to socialize could have a major impact on all subgroups across the board.

He also said many existing psychiatric conditions have been made worse by the added stress of the circumstances.

For example, the increased stress and anxiety has forced many psychiatric patients to make a switch in medication has their previous regimen was no longer effective.